Latest Share Price Volatility News

Botala Energy Ltd has denied holding undisclosed information following a sharp share price rise, linking the spike to a recent Serowe CBM Project announcement and confirming compliance with ASX disclosure rules.

Key Petroleum Ltd has wrapped up the last 3% tranche of its share placement, raising nearly $59,000 and exhausting its 15% ASX placement limit. The fresh capital is earmarked for asset acquisitions, development, and working capital.

Power Minerals has sealed its acquisition of the Morro do Ferro Rare Earths Project, a high-grade rare earth asset in Brazil, setting the stage for accelerated exploration and resource definition.

Gateway Mining attributes recent share price gains to a newly published independent research report, while confirming ongoing assay results from its Yandal Project remain under review and will be disclosed progressively starting 22 April 2026.

Red Sky Energy is raising approximately AUD 4.2 million through a fully underwritten non-renounceable rights issue priced at 0.1 cents per share. The capital will fund participation in Santos-operated wells and support ongoing operations.

Highfield Resources (ASX:HFR) has dismissed any undisclosed material information as the cause of its recent share price jump, attributing the volatility to global geopolitical tensions impacting fertiliser raw materials.

Legacy Minerals Holdings has addressed recent share price volatility, confirming no undisclosed material information while awaiting key assay results from its Mascotte Prospect drilling program.

Fiducian Group Limited has responded to a sharp share price drop by denying any undisclosed information and downplaying the impact of new APRA licence conditions on its operations.

Temas Resources Corp has opted to reduce its financial reporting frequency, moving from quarterly to semi-annual reports under a Canadian Securities Exchange pilot program. This change aligns with its status as a venture issuer and reflects its ongoing focus on proprietary processing technology and mineral projects.

EVE Health Group has announced a $1.3 million capital raising through a placement of shares and free attaching options, aimed at advancing its pharmaceutical product rollout and development pipeline. Several components of the offer await shareholder approval at an upcoming general meeting.

IperionX Limited has denied any undisclosed information following a sharp share price drop from $6.93 to $4.58, clarifying its accounting for U.S. government grants amid market volatility.

The ASX has suspended trading in eight companies for failing to lodge their periodic reports on time, raising fresh questions about compliance and market confidence.